Filing Details
- Accession Number:
- 0001181431-13-046989
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-29 18:25:39
- Reporting Period:
- 2013-08-27
- Filing Date:
- 2013-08-29
- Accepted Time:
- 2013-08-29 18:25:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1311596 | Regado Biosciences Inc | RGDO | Pharmaceutical Preparations (2834) | 030422069 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1579466 | Rusnanomedinvest Llc | Business-Center 29/22 Capital Tower 1-St Brestskaya Street Moscow 1Z 125047 | No | No | Yes | No | |
1579787 | S.a.r.l. Investments Rmi | Business-Center 29/22 Capital Tower 1-St Brestskaya Street Moscow 1Z 125047 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2013-08-27 | 1,369,988 | $0.00 | 1,369,988 | No | 4 | C | Direct | |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2013-08-27 | 3,866,529 | $4.00 | 5,236,517 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Series E Preferred Stock | Disposition | 2013-08-27 | 22,878,805 | $0.00 | 1,369,988 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct |
Footnotes
- The reportable securities are directly held by the Reporting Person. The Reporting Person is a wholly-owned subsidiary of RusnanoMedInvest LLC ("RMI LLC"). RMI LLC has voting and dispositive power over the shares held by the Reporting Person.
- The shares of Series E Preferred Stock had no expiration date and automatically converted upon the consummation of the initial public offering of Regado Biosciences, Inc. (the "Company") at a conversion ratio of 1 share of Series E Preferred Stock to 0.05988024 shares of common stock, for no additional consideration.